India 2007 © Sheila Shettle/MSF
The "Drop the Case" campaign called for drug giant Novartis to drop its legal case aimed at gutting India’s patent law of important public health safeguards.
For six years the drug company Novartis has refused to back down on its legal case to stop the production of affordable generic medicines in India. MSF with others continues its resolute opposition to this attack on life-saving medicines that save millions of lives in developing countries.

As the Indian Supreme Court readies to hear the Novartis case, MSF calls for Novartis to STOP its attack on India, the pharmacy of the developing world.
» TAKE ACTION NOW: Join MSF & tell Novartis patients matter more than profits

India 2007 © Sheila Shettle/MSF
The "Drop the Case" campaign called for drug giant Novartis to drop its legal case aimed at gutting India’s patent law of important public health safeguards.
India 2011 © Guddu
As the Novartis case opens before the Indian Supreme Court this month, join MSF & tell Novartis that people matter more than profits.
29 November 2011
Novartis case: New date and the government's defence
07 December 2011
Photos from World AIDS Day Action at Novartis offices in Mumbai
02 September 2011
What future for India’s Patent Act? Novartis vs. Union of India
08 August 2007
After Indian court ruling, MSF hands over petition with 420,000 signatures to Novartis

© MSF
Leena Menghaney, who works for the Access Campaign in New Delhi, describes one of the biggest challenges facing activists campaigning about the Novartis trial.

Switzerland 2007 © MSF
Nearly half a million people, including Archbishop Desmond Tutu, author John Le Carré and former Swiss President Ruth Dreifuss, signed our petition calling on Novartis to ‘Drop the Case’ in 2006.